Cargando…

Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report

Salivary duct carcinoma is a relatively rare salivary cancer, and most cases are androgen receptor -positive. Salivary duct carcinoma growth is suggested to be androgen dependent, which can reportedly be controlled by androgen deprivation therapy. However, the effectiveness and underlying molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasano, Koichiro, Sakurai, Kouhei, Kawasaki, Taiji, Kusafuka, Kimihide, Kasahara, Masao, Kondo, Naoki, Inada, Ken-ichi, Ogawa, Kaoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149030/ https://www.ncbi.nlm.nih.gov/pubmed/30263102 http://dx.doi.org/10.1177/2036361318798867

Ejemplares similares

Thyroid lobe size predicts risk of postoperative temporary recurrent laryngeal nerve paralysis
por: Tsuzuki, Nobuyoshi, et al.
Publicado: (2019)

Improving survival in salivary duct cancer with adjuvant androgen deprivation therapy
por: van Boxtel, Wim, et al.
Publicado: (2019)

Salivary duct carcinoma with rhabdoid features: Report of 2 cases with immunohistochemical and ultrastructural analyses
por: Kusafuka, Kimihide, et al.
Publicado: (2014)

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022)

Salivary adenoid cystic carcinoma with an early phase of high-grade transformation: case report with an immunohistochemical analysis
por: Kusafuka, Kimihide, et al.
Publicado: (2013)

Head and Neck Solitary Fibrous Tumor Presenting as Salivary Gland Tumor: Two Case Reports and Review of the Literature
por: Suzuki, Kensuke, et al.
Publicado: (2023)

Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
por: van Boxtel, Wim, et al.
Publicado: (2019)

Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report
por: Rösch, Manuel, et al.
Publicado: (2023)

Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature
por: You, Yongfei, et al.
Publicado: (2021)

Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
por: Boon, Eline, et al.
Publicado: (2017)

Patterns of hearing changes in women and men from denarians to nonagenarians
por: Wasano, Koichiro, et al.
Publicado: (2021)

Prevalence of Hearing Impairment by Age: 2nd to 10th Decades of Life
por: Wasano, Koichiro, et al.
Publicado: (2022)

Sudden sensorineural hearing loss in patients with vestibular schwannoma
por: Wasano, Koichiro, et al.
Publicado: (2021)

Author Correction: Sudden sensorineural hearing loss in patients with vestibular schwannoma
por: Wasano, Koichiro, et al.
Publicado: (2022)

Adenosquamous carcinoma of the parotid gland
por: Kusafuka, Kimihide, et al.
Publicado: (2013)

The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi‐institutional retrospective analysis in Japan
por: Kusafuka, Kimihide, et al.
Publicado: (2022)

Age‐related change of auditory functional connectivity in Human Connectome Project data and tinnitus patients
por: Minami, Shujiro B., et al.
Publicado: (2020)

Carcinoma Cuniculatum of the Maxilla Arising From Oroantral Fistula: A Report of an Extremely Rare Case
por: Muramatsu, Aya, et al.
Publicado: (2023)

Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer
por: Ishizaki, Fumio, et al.
Publicado: (2013)

Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
por: Memon, Maaz A., et al.
Publicado: (2022)

Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score
por: Akaza, Hideyuki, et al.
Publicado: (2013)

Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
por: Morita, Naruhiko, et al.
Publicado: (2021)

Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade
por: Lassche, Gerben, et al.
Publicado: (2021)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Affections of the salivary ducts in buffaloes
por: Misk, N.A., et al.
Publicado: (2014)

First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study
por: Viscuse, Paul V., et al.
Publicado: (2019)

Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab
por: Watanabe, Hirofumi, et al.
Publicado: (2020)

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
por: Onozawa, Mizuki, et al.
Publicado: (2018)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study
por: Okumura, Yoshihide, et al.
Publicado: (2020)

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy
por: Hirata, Yoshito, et al.
Publicado: (2015)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Salivary duct carcinoma of parotid gland
por: Kinnera, Vijay Sreedhar Babu, et al.
Publicado: (2009)

Salivary duct carcinoma of the parotid gland
por: Mlika, Mona, et al.
Publicado: (2012)

Salivary duct carcinoma of accessory parotid
por: Al-Hashim, Mohammed A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l6i2b1t3ce5q3pjpv9mldpri36